- Home
- Site Contents
- Our Founder
- Governance
- Faculty
- Strategic Plan
- Core Values
- Resources
- Programs - Research
- Programs - Education
- Programs - Service
- Other Activities
- Conferences (2013-7)
- Conferences (2018)
- Conferences (2019)
- Conferences (2020)
- Conferences (2021)
- Press Releases (2008-9)
- Press Releases (2010-5)
- Patents & Books
- Book Contributions
- Refereed Articles -1
- Referred Articles - 2
- Abstracts - 1
- Abstracts - 2
- Abstracts - 3
- Personnel - CVs
- Philanthropy
- Privacy Policy
REFEREED ARTICLES - 1
2008
G. Ristagno, W. Tang, L. Huang, A. L. Fymat, Y-T Chang, S. Sun, C. Castillo, and M. H. Weil, Epinephrine Reduces Cerebral Perfusion During Cardiopulmonary Resuscitation, Journal of Critical Care Medicine 37(4):1408-15, 2008. doi: 10.197/CCM.0b013e31819cedc9.
2013
A. L. Fymat,Magnetic Resonance Imaging with Nanocontrasting Materials, Invited Address presented at the BIT's 4thAnnual Congress in Nanomedicine, Shuzou, China, June 2013.
A. L. Fymat, Creating New Biomedical Ventures. Invited Address presented at the 1stInternational Scientific Conference of the Society for the Advancement of Science in Africa, 2013, Polokwane, South Africa.
A.L. Fymat, Contributors to Sickness: Epigenetic Regulators of Many Gene Expressions, Invited Address presented at the 2ndInternational Scientific Conference of the Society for the Advancement of Science in Africa, 2013, Polokwane, South Africa.
A. L. Fymat, A Paradigm Shift in Medicine and Health Care, Invited Address presented at the 2ndInternational Scientific Conference of the Society for the Advancement of Science in Africa, August 2014, Kampala, Uganda.
2015
A. L. Fymat, Perspectives on Drug Manufacturing in Africa, Invited Address presented at the 3rdInternational Scientific Conference of the Society for the Advancement of Science in Africa, August 2015, Toronto, Canada.
A. L. Fymat, Generic Drugs Manufacturing in Africa: A Contextual Review of Interest to Africa, Invited Address presented at the 4thInterna
2016
A. L. Fymat, Recent Research Developments in Anti-Cancer Therapy. Journal of Cancer Prevention & Current Research (Editorial) (2016), 5(2):1-2.00155. doi: 10.15406/ jcpcr.2016.05.00155. https://medcraveonline.com/JCPCR/JCPCR-05-00155.pdf(22 June 2016).
A. L. Fymat,Nanotechnology and Cancer,Journal of Cancer Prevention & Current Research (2016), 5(6):1-7, 00180. doi: 10.15406/jcpcr.2016.05.00180. https://medcraveonline.com/JCPCR/JCPCR-05-00180.pdf(20 September 2016).
A. L. Fymat, A New Digital Paradigm in Medicine and Health Care, Invited Address presented at the Health 2.0 Asia 2016, International Summit on Smarter Healthcare & Great Health Industry, Theme: Intelligent Innovation, Healthy Future, Nanjing, China, November 9-10, 2016.
A. L. Fymat, The Long Quest for Cancer Cures, Journal of Cancer Prevention & Current Research (Editorial) (2016), 6(2):1-3, 00201. doi: 10.15406/jcpcr.2016.06.00201(30 November 2016).
A. L. Fymat, Recent Developments in Nanomedicine Research, Journal of Nanomedicine Research (2016). 4(4):1-12, 00096. doi: 10.15406/jnmr.2016.04.00096(12 December 2016).
2017
A. L. Fymat, On Cancer Electro- and Nano-Chemotherapy, Journal of Cancer Prevention & Current Research (Perspective) (2017),7(2):1-4:00232. doi: 10.15406/jcpcr.2017.07.00232(20 January 2017).
A. L. Fymat,Immunotherapy: An Emergent Anti-Cancer Strategy, Journal of Cancer Prevention & Current Research (Editorial) (2017). 7(3):1-4, 00233. doi: 10.15406/jcpcr.2017.07.00233. https://medcraveonline.com/JCPCR/JCPCR-07-00233.pdf (2 February 2017).
A. L. Fymat, Nanochemotherapy: An Emergent Anti-Cancer Modality, Global Journal of Nanomedicine (Editorial) (2017). 1(1):1-6. 555555 (6 February 2017).
A. L. Fymat,Nanoneurology: Drug Delivery Across the Brain Protective Barriers, Journal of Nanomedicine Research (2017). 5(1):1-4, 00105. doi: 10:15406/jnmr/2017.05.00105(9 February 2017).
A. L. Fymat, Magnetic Resonance Imaging Modalities with Nanocontrasting Materials, Journal of Current Trends in Clinical & Medical Imaging (2017) 1(1):1-4. 555554. (14 February 2017).
A.L. Fymat, Synthetic Immunotherapy with Chimeric Antigen Receptors, Journal of Cancer Prevention & Current Research (2017). 7(5):1-3. 00253: doi: 10.15406/jcpcr.2017.07.00253. (22 March 2017).
A.L. Fymat, Genetics, Epigenetics and Cancer, Cancer Therapy & Oncology International Journal (2017). 4(2):1-11. 555634. doi: 10.19080/CTOIJ.2017.04.555634(7 April 2017).
A. L. Fymat, Nanooncology: Perspective on Promising Anti-Tumor Therapies, Journal of Tumor Medicine & Prevention (2017). 1(1):1-10, 555555 (24 April 2017).
A. L. Fymat, Disrupting Cell Mitoses to Provoke Cancer Self-Destruction, Cancer Therapy & Oncology International Journal (2017). 5(1):1-4, 555655. doi: 10.19080/CTOIJ.2017.05.555655, (10 May 2017).
A. L. Fymat, Anti-Tumor Therapies - Cases of Breast and Prostate Cancers, Journal of Tumor Medicine & Prevention (2017). 1(2):1-12, 555559(16 June 2017).
A. L. Fymat, Antibiotics and Antibiotic Resistance, Biomedical Journal of Science & Technology Research Open Access, (2017). 1(1):1-16. doi:10.26717/BJSTR.2017.01.000117(5 June 2017).
A. L. Fymat, Therapeutics Delivery Behind, Through and Beyond the Blood Brain Barrier, Open Access Journal of Surgery (2017). 5(1): 1-9; 555654. doi: 10.19080/OAJS.2017.05.555654 (26 June 2017).
A. L. Fymat,Glioblastoma Treatments: Where Do We Stand? (2017). MedPlus Journal of Cancer & Oncology Research 1(1)1-12 (16 August 2017).
A. L. Fymat,On Cancer's Theories, True Nature, and Possible Self-Eradication, Cancer Therapy & Oncology International Journal (2017), 7(2):1-3, doi: 10.19080/CTOIJ.2017.07.555709 (4 October 2017).
A. L. Fymat, Antiangiogenic Targeting of Early Developing Glioblastoma Behind a Weakened Blood Brain Barrier (2017). Journal of Anti-Tumor Medicine & Prevention 2(3):1-6 (27 October 2017).
A. L. Fymat, Nanomedicine as a Precursor to Precision Medicine for Glioblastoma Treatment, Journal of Current Opinions in Neurological Science (2017). 1(4):200-206. ISSN:2575-5447(31 October 2017).
A. L. Fymat,Immunotherapy of Brain Cancers and Neurological Disorders, Journal of Cancer Prevention & Current Research (2017). 8(6):1-7; 00301. doi: 10.15406/jcpcr2017.08.00301 (29 November 2017).
A. L. Fymat,Surgical and Non-Surgical Management and Treatment of Glioblastoma: II. Recurring Tumors, Open Access Journal of Surgery (2017). 7(1):1-7, doi: 10.19080/OAJS.2017.07.555703, ISSN:2476-1346, (November 16, 2017).
A. L. Fymat,Epilepsy: A Review, Journal of Current Opinions in Neurological Science (2017). 1(5):240-254, ISSN: 2575-5447 (21 November 2017).
A. L. Fymat, Immuno-Therapy: A New Frontier in Cancer Care, Holistic Approaches in Oncotherapy Journal (Editorial) (2017). 1(1):8-13 (22 November 2017).
A. L. Fymat, Cancer Therapy with Chimeric Antigen Receptors – A Landmark Moment for Cancer Immunotherapy, Journal of Cancer Prevention & Current Research (017). 8(6):1-7. 009. doi: 10.15406/jcpcr.2017.08.00300(28 November 2017).
A. L. Fymat,Surgical and Non-Surgical Management and Treatment of Glioblastoma: I. Primary Tumors, Open Access Journal of Surgery(2017). 7(2):1-8. doi: 10.19080/OAJS 2017 07 555706, ISSN: 2476-1346(8 December 2017).
A. L. Fymat, The Evolving Paradigm of Statins, Chronicles of Medicine and Surgery Journal (Editorial) (2017). 1(2):47-50 (9 December 2017).
A. L. Fymat,Neurological Disorders and the Blood Brain Barrier: 1. Epilepsy, Journal of Current Opinions in Neurological Science (2017). 1(6):277-293, ISSN: 2575-5447(4 December 2017).
A. L. Fymat, On Mammography and Hormone Replacement Therapy, Interventions in Gynecology & Women's Healthcare (Editorial). 1(1):1-4, IGWHC MS ID.000101 (12 December 2017).
A. L. Fymat,On the Inflammation Theory of Cancer, Cancer Therapy and Oncology International Journal (2017). 8(3):1-7. doi: 10.19080/CTOIJ, 2017.08.555740 (19 December 2017).
A. L. Fymat, Parkinson's Disease and Other Movement Disorders: A Review, Journal of Current Opinions in Neurological Science (2017). 2(1):316-343, ISSN:2575-5477.(23 December 2017).
2018
A. L. Fymat, Neurological Disorders and the Blood Brain Barrier: 2. Parkinson's Disease and Other Movement Disorders, Journal of Current Opinions in Neurological Science (2017). 2(1)362-383. ISSN:2575-5447 (25 January 2018).
A. L. Fymat,Blood Brain Barrier Permeability and Neurological Diseases, Journal of Current Opinions in Neurological Science (Editorial). (2018). 2(2);411-414. ISSN: 2575-5447(6 February 2018).
A. L. Fymat,Alzheimer's Disease: A Review, Journal of Current Opinions in Neurological Science (2017). 2(2);415-436, ISSN: 2575-5447(3 March 2018).
A. L. Fymat, Regulating the Brain's Autoimmune System: The End of All Neurological Disorders? Journal of Current Opinions in Neurological Science (2018). 2(3):475-479. ISSN:2575-5447. (9 April 2018).
A. L. Fymat, Nanobiotechnology Advances in Oncology, Advances in Bioengineering & Biomedical Science Research (2018). 1(1):1-6 (16 April 2018).
A.L. Fymat,Roles of Nanomedicine in Clinical Neuroscience, Global Journal of Nanomedicine (2018). 4(1):13-15 (2018). ISSN:2573-2374. doi:10.19080/GJN.2018.04.555629(9 April 2018).
A. L. Fymat,Alzheimer's Disease: Prevention, Delay, Minimization and Reversal, Journal of Clinical Research in Neurology (2018) 1(1):1-16 (April 2018).
A. L. Fymat, Innate Immunotherapy of Recurring Glioblastomas: Preliminary Trials with Neutrophils, Journal of Current Opinions in Neurological Science (2018) 2(3):480-482. ISSN: 2575-5447.(25 April 2018).
A. L. Fymat,Neutrophils-Mediated Treatment of Neurodegenerative and Other Inflammatory Diseases, Journal of Clinical Research in Neurology (2018) 1(1):1-5 (May 2018).
A. L. Fymat, On Medical Avatars in the Diagnosis and Treatment of Endometriosis, Interventions in Gynecology & Women's Healthcare (Editorial) 2(2):1-2 (13 June 2018). doi:10.32474/IGWHC.2018.-02.000133.
A. L. Fymat,Harnessing the Immune System to Treat Cancers and Neurodegenerative Diseases, Journal of Clinical Research in Neurology 1(1):1-14, 2018 (June 2018).
A. L. Fymat, Is Alzheimer an Autoimmune Disease Gone Rogue”, Journal of Clinical Research in Neurology 2(1):1-4, 2018 (September 2018). ISSN: 2638,7662.
A. L. Fymat,On Cancer-Fighting Nanorobots, Journal of Cancer Prevention and Current Research, 9(5):255 (October 2018).
A. L. Fymat,Oncogenomics: A Personalized Cancer Therapy, Journal of Cancer Prevention and Current Research 9(6):306-311. doi:10.15406/jcpcr.2018.09.00373(November 28, 2018).
A. L. Fymat, Dementia Treatment: Where Do We Stand?, Journal of Current Opinions in Neurological Science 3(1):1-3. 599.603. ISSN: 2575-5447.(November 2018).
A.L. Fymat.On Dementia and Other Cognitive Disorders, Journal of Clinical Research in Neurology 2(1):1-14, 2019 (December 2018).
A. L. Fymat, Nanomedicine May Provide New Hope for Brain Cancer Therapy, Global Journal of Nanomedicine 4(5):1-7 (December 2018).
A. L. Fymat,Oncoepigenomics and Oncoecogenomics: Personalizing the Cancer Treatment, Open Access Journal of Oncology 1(2):1-14 (December 2018).